HBM NYSE Week ended 24 Jul 2026

Weekly Investor Report

Hudbay Minerals Inc. · Basic Materials · Copper

Open interactive chart View report data
Latest close 22.35 USD
9.8% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -5.7% below the Trend Line and sits at 57.8% of its 52-week range. The latest completed week returned 9.8%, after a -4.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 0d.

Setup score 41 out of 100
Latest Close 22.35 USD 24 Jul 2026
1W Return 9.8% latest completed week
4W Return -4.1% short-term follow-through
12W Return -1.9% quarterly tape
Trend Breadth 94.2% 49 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 60.09% based on similar historical setup states.
  • Activity pressure is constructive, supporting the smart-money activity read.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 9.8% Latest completed week; four-week move -4.1%. Indicator stack 52/2 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 60.09% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 52/100 conviction; expected move 14.2%. News sentiment 56/100 62 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -5.7% below the Trend Line and sits at 57.8% of its 52-week range. The latest completed week returned 9.8%, after a -4.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6412-week average 0.70

12-week confirmation

Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.64Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.1% over four weeks, -1.9% over 12 weeks, and 126.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W9.8%
4W-4.1%
12W-1.9%
26W-10.4%
52W126.7%
Active trend streak0 weeks
Active weeks in one year49
Trend breadth94.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.07Latest activity-pressure read.
Pressure change-360.1%Four-week change in activity pressure.
Leadership4.52Latest relative-leadership reading.
RS change-68.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength96/100Blend of value, momentum, and quality. Underlying universe rank 5; rank 1 is best.
Value79/100Relative valuation strength. Underlying universe rank 22; rank 1 is best.
Quality86/100Profitability and accounting quality. Underlying universe rank 15; rank 1 is best.
Momentum96/100Medium-term price momentum. Underlying universe rank 5; rank 1 is best.
Growth94/100Revenue and earnings growth. Underlying universe rank 7; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework86/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
15.1x
Price divided by trailing earnings.
Price / sales
4.2x
Market value relative to trailing revenue.
EV / EBITDA
6.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
12.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
37.1%
Gross profit retained from each unit of revenue.
Operating margin
49.2%
Operating profit retained from revenue.
Free-cash-flow margin
55.0%
Free cash flow generated from revenue.
Return on invested capital
19.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
13.5%
Latest one-year revenue growth.
EPS growth
325.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
26.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.1%
Cash dividends relative to market value.
Buyback yield
-0.3%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

HBM shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.05, expected move of 14.2%, and Sharemaestro trend signal inactive.

Conviction52/100
Expected move14.2%
Put/call volume0.05
Pressure98
Speculation7
Volatility91
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 62 relevant articles.

27 positive · 28 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
Options expected move14.2%Nearest-chain priced movement where available.
52-week drawdown-30.5%Distance below the 52-week high.
13-week volatility9.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+19.6%Week of 29 May.
Worst week-21.3%Week of 6 Mar.
Latest week+9.8%Week of 24 Jul.

Shape of recent returns

Strong gains11
Modest gains0
Flat weeks0
Modest losses4
Sharp losses11
Recent vol9.4%13-week weekly-return volatility.
Base vol8.1%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew7.3% / -6.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape42/100

Trend, activity pressure, participation, and risk combine to a 42/100 tape read.

 Indicator analysis61/100

Latest 12-week confirmation: trend 9/12, activity pressure 5/12, relative leadership 11/12.

Activity pressure 0.64; 2 reversal markers Next-Week ExpectancyPositive 60.09%

Next-week expectancy is positive with a 60.09% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors88/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 74; Small Cap Core rank 70 SVQF86/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 147.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options35/100

HBM shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.05, expected move of 14.2%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 14.2% Sentiment56/100

Weighted news tone is neutral across 62 relevant articles.

Hudbay Minerals Inc (HBM) Stock Up 3.5% but GF Value Says Overvalued -- GF Score: 75/100 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings0d

Next report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202622.35 USD9.8%23.70 USD11.61 USD-1.074.5225.2MOff
17 Jul 202620.36 USD-5.9%23.63 USD11.50 USD-0.80-4.4121.7MOff
10 Jul 202621.64 USD-4.2%23.60 USD11.40 USD-0.370.8222.0MOff
3 Jul 202622.59 USD-3.0%23.50 USD11.30 USD0.127.5319.4MOn
26 Jun 202623.30 USD-15.5%23.33 USD11.19 USD0.4114.3128.7MOn
19 Jun 202627.59 USD-0.8%23.12 USD11.07 USD0.5233.4919.4MOn
12 Jun 202627.82 USD8.4%22.69 USD10.92 USD0.2637.8332.6MOn
5 Jun 202625.65 USD-12.0%22.29 USD10.77 USD0.0529.7537.0MOn
29 May 202629.15 USD19.6%21.97 USD10.64 USD-0.1445.7027.5MOn
22 May 202624.38 USD-2.2%21.53 USD10.48 USD-0.4825.7621.0MOn
15 May 202624.94 USD-0.3%21.25 USD10.36 USD-0.4531.4636.5MOn
8 May 202625.01 USD9.7%20.96 USD10.23 USD-0.6134.1127.3MOn
1 May 202622.79 USD-6.4%20.68 USD10.10 USD-0.6827.0322.7MOn
24 Apr 202624.34 USD-5.9%20.45 USD9.98 USD-0.7138.9126.6MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.